Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megumi Mathison

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 9, 2005
A clinically relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materialsJianhua Cui, Jinsheng Li, Megumi Mathison, et al.
Journal of the American Heart Association|December 10, 2021
Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte ReprogrammingVivek P Singh, Jaya P Pinnamaneni, Aarthi Pugazenthi, et al.
Circulation|September 15, 2005
Extracellular matrix scaffold for cardiac repairKeith A Robinson, Jinshen Li, Megumi Mathison, et al.
Scientific Reports|October 15, 2024
Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potentialHong Gao, Saliha Pathan, Beverly R E A Dixon, et al.
Scientific Reports|July 6, 2022
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiationJaya Pratap Pinnamaneni, Vivek P Singh, Mary B Kim, et al.
Biomaterials Science|August 16, 2020
Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardiumRavi K Ghanta, Samira Aghlara-Fotovat, Aarthi Pugazenthi, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 25, 2016
In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regenerationMegumi Mathison, Vivek P Singh, Maria J Chiuchiolo, et al.
Journal of the American Heart Association|January 15, 2013
In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factorMegumi Mathison, Robert P Gersch, Ahmed Nasser, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 3, 2018
p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cellsVivekkumar Patel, Vivek P Singh, Jaya Pratap Pinnamaneni, et al.
Journal of Hematology & Oncology|October 5, 2017
The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesisLina Yang, Li Liu, Hong Gao, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 9, 2005
A clinically relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materialsJianhua Cui, Jinsheng Li, Megumi Mathison, et al.
Journal of the American Heart Association|December 10, 2021
Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte ReprogrammingVivek P Singh, Jaya P Pinnamaneni, Aarthi Pugazenthi, et al.
Circulation|September 15, 2005
Extracellular matrix scaffold for cardiac repairKeith A Robinson, Jinshen Li, Megumi Mathison, et al.
Scientific Reports|October 15, 2024
Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potentialHong Gao, Saliha Pathan, Beverly R E A Dixon, et al.
Scientific Reports|July 6, 2022
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiationJaya Pratap Pinnamaneni, Vivek P Singh, Mary B Kim, et al.
Biomaterials Science|August 16, 2020
Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardiumRavi K Ghanta, Samira Aghlara-Fotovat, Aarthi Pugazenthi, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 25, 2016
In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regenerationMegumi Mathison, Vivek P Singh, Maria J Chiuchiolo, et al.
Journal of the American Heart Association|January 15, 2013
In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factorMegumi Mathison, Robert P Gersch, Ahmed Nasser, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 3, 2018
p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cellsVivekkumar Patel, Vivek P Singh, Jaya Pratap Pinnamaneni, et al.
Journal of Hematology & Oncology|October 5, 2017
The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesisLina Yang, Li Liu, Hong Gao, et al.
Pageof 3